This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Hiroyuki Kakei: Innovator in Quinoxaline Compounds
Introduction
Hiroyuki Kakei is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Hiroyuki Kakei holds a patent for "Quinoxaline compounds and uses thereof." This invention provides compounds of formula I and subsets thereof, wherein T, J, R, R, R, o, R, and R are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, or T-cell mediated autoimmune disease. He has 1 patent to his name.
Career Highlights
Kakei is associated with Millennium Pharmaceuticals Limited, where he continues to work on innovative solutions in the pharmaceutical industry. His research focuses on developing compounds that can address significant health challenges.
Collaborations
Throughout his career, Hiroyuki Kakei has collaborated with esteemed colleagues, including Kenneth M Gigstad and David P Cardin. These collaborations have contributed to the advancement of his research and the development of new therapeutic compounds.
Conclusion
Hiroyuki Kakei's work in quinoxaline compounds showcases his commitment to innovation in the pharmaceutical field. His contributions have the potential to impact the treatment of various diseases significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile